Advertisement
Home »

Human Proteome Microarray identifies autoantibodies to tumor-associated antigens as serological biomarkers for the diagnosis of hepatocellular carcinoma.

Jan 02, 2023

REFERENCES & ADDITIONAL READING

PubMed

ABOUT THE CONTRIBUTORS

  • Qian Yang

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Prenatal Diagnosis Center. The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan Province, China.

    Hua Ye

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Epidemiology and Health Statistics and Henan Key Laboratory of Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan Province, China.

    Guiying Sun

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Epidemiology and Health Statistics and Henan Key Laboratory of Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan Province, China.

    Keyan Wang

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450002, Henan Province, China.

    Liping Dai

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450002, Henan Province, China.

    Cuipeng Qiu

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Epidemiology and Health Statistics and Henan Key Laboratory of Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan Province, China.

    Jianxiang Shi

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450002, Henan Province, China.

    Jicun Zhu

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Epidemiology and Health Statistics and Henan Key Laboratory of Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan Province, China.

    Xiao Wang

    Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450002, Henan Province, China.

    Peng Wang

    The State Key Laboratory of Esophageal Cancer Prevention & Treatment, Zhengzhou University, Zhengzhou, Henan Province, China.

    Department of Epidemiology and Health Statistics and Henan Key Laboratory of Tumor Epidemiology, College of Public Health, Zhengzhou University, Zhengzhou, 450001, Henan Province, China.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement